Category : Seeking Alpha

Fastsættelse af kuponrenter - Nykredit Realkredit A/S

Til Nasdaq Copenhagen

Fastsættelse af kuponrenter (Senior, Non-Preferred Note)

DLR Kredit A/S

Flow Capital Announces $1.5 Million of Follow-On Investments to a Fintech Company

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”), a leading provider of flexible growth capital and alternative debt solutions, announces $1.5 million of follow-on investments made over the...

Prospect Capital’s Credit Ratings Reaffirmed Investment Grade by Morningstar DBRS with Stable Trend

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) ("Prospect", “our”, or “we”) today announced that Morningstar DBRS ("DBRS") has reaffirmed Prospect’s investment grade issuer and long term senior debt credi...

FDA Issues Complete Response Letter for Etripamil for PSVT

CRL focused on CMC; no clinical issues relating to etripamil raised

Aya Gold & Silver Reports Q4 and Full Year 2024 Results; Announces 2025 Production and Cost Guidance

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced financial and operational results for the fourth quarter and full year ended December 31, 2024. All amount...

Aya Or & Argent annonce ses résultats pour le T4 et l’exercice 2024 et présente ses prévisions pour 2025 en termes de production et de coûts

MONTRÉAL, 28 mars 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a annoncé aujourd’hui ses résultats financiers et opérationnels pour le quatrième trimestre et l’exercice financier term...

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the peer-reviewed publication titled “A Phase 1, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, i...

Tulikivi Corporation’s annual report for 2024 has been published

TULIKIVI CORPORATION STOCK EXCHANGE RELEASE 28 MARCH 2025 AT 13:00

Tulikivi Oyj:n vuoden 2024 vuosikertomus on julkaistu

Bio-Path Holdings Reports Full Year 2024 Financial Results

Reports Continued Progress Across Both Obesity and Oncology Franchises Reports Continued Progress Across Both Obesity and Oncology Franchises

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

RIPSA interests repurchased

Signet Bank Initiated Coverage of Šiaulių Bankas at target price of EUR 1.27

28 March 2025, Signet, one off the leading Latvian investment banks, has initiated sponsored research of AB Šiaulių Bankas and published the initiation of coverage report. Analysis suggests a target price of EUR 1.27, which represents a compelling 35...

„Signet“ bankas inicijavo Šiaulių banko akcijų sekimą nustatydamas 1,27 euro tikslinę kainą

2025 m. kovo 28 d. „Signet“ bankas, vienas investicinės bankininkystės lyderių Latvijoje, AB Šiaulių banko užsakymu įtraukė banką į stebimų įmonių sąrašą ir paskelbė pirminę apžvalgą. Analitikų nustatyta tikslinė Šiaulių banko akcijos kaina yra 1,27...